Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/1999
04/01/1999CA2304451A1 Specific immunophilin ligands useful as anti-asthmatic, anti-allergic, anti-rheumatic, immunosuppressive, antipsoriatic and neuroprotective agents
04/01/1999CA2304397A1 Carboxamidothiazole derivatives, preparation, pharmaceutical compositions containing them
04/01/1999CA2304283A1 Parasiticidal formulations
04/01/1999CA2304274A1 Benzyl-biphenyls and analogous compounds and the application thereof in order to treat arteriosclerosis and dyslipidaemia
04/01/1999CA2304202A1 Use of citrus limonoids and flavonoids as well as tocotrienols for the treatment of cancer
04/01/1999CA2304191A1 Topical non-steroidal anti-inflammatory drug composition
04/01/1999CA2304162A1 Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
04/01/1999CA2304138A1 Benzothiophenes
04/01/1999CA2304115A1 Treatment of oppositional defiant disorder
04/01/1999CA2304114A1 Methods for regulating trka expression
04/01/1999CA2304112A1 Treatment of attention-deficit/hyperactivity disorder
04/01/1999CA2304042A1 Nicotine compositions and methods of formulation thereof
04/01/1999CA2304005A1 Compositions and methods for treating respiratory disorders
04/01/1999CA2304000A1 Vitronectin receptor antagonist
04/01/1999CA2303994A1 N-5,6,7,8-tetrahydro(1,6)naphthyridine-n'-phenylurea derivatives
04/01/1999CA2303943A1 2-aminotetralines, a process for their preparation, and pharmaceutical compositions, for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies
04/01/1999CA2303918A1 Use of 6,7-substituted 2-aminotetralines suitable for preparing pharmaceutical composition for the therapeutic treatment of inflammatory and/or autoimmune pathologies
04/01/1999CA2303883A1 C3a receptor ligands
04/01/1999CA2303863A1 Smoking products containing antioxidants
04/01/1999CA2303856A1 Antiviral polymers comprising acid functional and hydrophobic groups
04/01/1999CA2303846A1 Vitronectin receptor antagonist
04/01/1999CA2303528A1 New npy antagonists
04/01/1999CA2303527A1 Linker nucleoside, its preparation and use
04/01/1999CA2303487A1 Vitronectin receptor antagonists
04/01/1999CA2303359A1 1,5-diphenylpyrazole derivatives
04/01/1999CA2303147A1 Small particle liposome aerosols for delivery of anti-cancer drugs
04/01/1999CA2303096A1 Binuclear complex
04/01/1999CA2302936A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
04/01/1999CA2302572A1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors
04/01/1999CA2301957A1 Antisense oligonucleotides against thymidylate synthase
04/01/1999CA2301614A1 Thrombin inhibitors
04/01/1999CA2300051A1 Amide derivatives for the treatment of diseases mediated by cytokines
04/01/1999CA2246004A1 A kringle-related clone, hthbz47
03/1999
03/31/1999EP0905512A1 Method of identification of leads or active compounds
03/31/1999EP0905257A1 Process for preparing optically active 2-amino-Omega-oxoalkanoic acid derivatives
03/31/1999EP0905255A2 Process for the preparation of pharmaceutically active thiazolidine or oxazolidine compounds by a yeast reductase
03/31/1999EP0905253A2 Adenoviral vector deleted of all E4-ORF except ORF6
03/31/1999EP0905250A1 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratA
03/31/1999EP0905249A2 Alcohol dehydrogenase
03/31/1999EP0905248A1 Staphylococcus aureus MurE protein and nucleic acids encoding it
03/31/1999EP0905247A2 MurF polynucleotides and polypeptides from Staphylococcus
03/31/1999EP0905245A1 Staphylococcal polypeptides Spo0J1
03/31/1999EP0905243A2 Polynucleotides from Staphylococcus aureus expressed in infected tissue
03/31/1999EP0905238A2 Pigrl-1, a member of immunoglobin gene superfamily
03/31/1999EP0905237A2 PIGR-2 A member of immunoglobulin gene superfamily
03/31/1999EP0905236A1 Transcription factor DP-1
03/31/1999EP0905233A2 Staphylococcus aureus trigger factor
03/31/1999EP0905139A2 5 ring heterocyles, process for preparation, use as inhibitors of leukocyte adhesion and pharmaceutical preparations comprising them
03/31/1999EP0905136A1 Tetrahydro gamma-carbolines
03/31/1999EP0905132A1 Benzothiophenes
03/31/1999EP0905131A1 Sulfonamid-substituted chromans, process for their preparation, their use as medicine, and pharmaceutical preparation containing them
03/31/1999EP0905130A1 A process for the production of taxol
03/31/1999EP0905129A1 Substituted amidinobenzene derivatives and medicinal compositions thereof
03/31/1999EP0905126A1 Metalloproteinase inhibitors
03/31/1999EP0905118A1 Unsaturated 6-tert-butyl-1,1-dimethylindane derivates substituted in the 4-position and their use in human and veterinary medicine as well as in cosmetics
03/31/1999EP0904783A1 Benzo(b)thiophene derivatives for lowering platelet counts
03/31/1999EP0904782A1 Remedy for spinal injury
03/31/1999EP0904781A2 Improved pharmaceutical composition comprising fenofibrate
03/31/1999EP0904780A1 Pharmaceutical compositions suitable for use against histomoniasis
03/31/1999EP0904777A1 Use of an excitatory amino acids inhibitor in cosmetic or dermatological compositions for sensitive kin and composition obtained
03/31/1999EP0904774A1 Resorcinol derivatives
03/31/1999EP0904694A1 Antimicrobial agents for eucaryotic microorganisms and methods of growth suppression of eucaryotic microorganisms using these agents
03/31/1999EP0904693A1 Pseudoplastic film-forming acidic chlorite composition as teat dip
03/31/1999EP0904543A1 Use of rc-9 in diagnosis and treatment of proliferative arterial disease
03/31/1999EP0904394A1 Chicken embryo lethal orphan (celo) virus
03/31/1999EP0904392A1 Retroviral vectors
03/31/1999EP0904384A2 Tyrosine-phosphatase-related protein
03/31/1999EP0904380A2 Synthetic hiv genes
03/31/1999EP0904379A2 Simian-human hav having a chimeric 2c protein
03/31/1999EP0904378A1 Hepatitis b monoclonal antibodies
03/31/1999EP0904373A1 Targeted delivery of genes encoding interferon
03/31/1999EP0904372A2 Human phospholipase inhibitor
03/31/1999EP0904369A1 Autoantigen and proteins structurally related thereto for use in immunotherapy of autoimmune diseases
03/31/1999EP0904367A1 Scf analog compositions and methods
03/31/1999EP0904366A1 Apo-2li and apo-3 apoptosis polypeptides
03/31/1999EP0904361A1 Immobilized alliinase and continuous production of allicin
03/31/1999EP0904351A1 Animal cells and processes for the replication of influenza viruses
03/31/1999EP0904339A1 Sterol extraction with polar solvent to give low sterol, high triglyceride, microbial oil
03/31/1999EP0904313A1 Absolute molecular weight polymers and methods for their use
03/31/1999EP0904299A1 Synthetic polysaccharides, method for preparing same and pharmaceutical compositions containing said polysaccharides
03/31/1999EP0904292A1 Growth differentiation factor-14
03/31/1999EP0904291A2 Antipathogenic peptides and compositions comprising them
03/31/1999EP0904288A2 Pathogenic escherichia coli associated protein
03/31/1999EP0904285A1 Cyclic adhesion inhibitors
03/31/1999EP0904284A1 6-substituted amino-4-oxa-1-azabicyclo (3,2,0) heptan-7-one derivatives as cysteine protease inhibitors
03/31/1999EP0904283A1 Human netrin-1
03/31/1999EP0904282A1 Novel cationic cholesteryl derivatives containing cyclic polar groups
03/31/1999EP0904281A1 STREPTOCOCCUS PNEUMONIAE HISTIDYL tRNA SYNTHETASE
03/31/1999EP0904280A1 STREPTOCOCCUS PNEUMONIAE ASPARTYL tRNA SYNTHETASE
03/31/1999EP0904278A1 Apoptosis inducing molecule ii
03/31/1999EP0904277A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease
03/31/1999EP0904274A1 Farnesyl transferase inhibitors
03/31/1999EP0904273A1 Mesylate trihydrate salt of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2(1h)-indol-2-one (=ziprasidone), its preparation and its use as dopamine d2 antagonist
03/31/1999EP0904272A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
03/31/1999EP0904271A1 5,6,7,8-TETRAHYDROPYRIDO[2,3-d]PYRIMIDINES
03/31/1999EP0904270A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
03/31/1999EP0904269A1 3,4-diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to cox-2 inhibitors
03/31/1999EP0904266A1 Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
03/31/1999EP0904262A1 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
03/31/1999EP0904260A1 Inhibition of matrix metalloproteases by 2-(omega-aroylalkyl)-4-biaryl-oxobutyric acids
1 ... 6519 6520 6521 6522 6523 6524 6525 6526 6527 6528 6529 6530 6531 6532 6533 6534 6535 6536 6537 6538 6539 ... 7860